CROMOLYN SODIUM (CROMOLYN SODIUM)
- Maintenance therapy for asthma
- Systemic mastocytosis
- Gastrocrom Oral Solution
- Gastrocrom Oral Soln
- Gastrocrom Oral Concentrate
- Cromolyn Solution For Nebulization
- Cromolyn Oral Solution
- Cromolyn Oral Concentrate
- By Indication
100 mg/5 mL oral concentrate
- 200 mg (2 ampules) and squeeze contents into a glass of water and stir by oral route 4 times per day 30 min before meals and at bedtime
100 mg/5 mL oral concentrate
- 200 mg (2 ampules) and squeeze contents into a glass of water and stir by oral route 4 times per day 30 min before meals and at bedtime
100 mg/5 mL oral concentrate
- 200 mg (2 ampules) and squeeze contents into a glass of water and stir by oral route 4 times per day 30 min before meals and at bedtime
cromolyn 20 mg/2 mL solution for nebulization
- Inhale 2 milliliters (20 mg) by nebulization route 4 times per day
cromolyn 100 mg/5 mL oral concentrate
- 200 mg (2 ampules) and squeeze contents into a glass of water and stir by oral route 4 times per day 30 min before meals and at bedtime
cromolyn 100 mg/5 mL oral concentrate
- 200 mg (2 ampules) and squeeze contents into a glass of water and stir by oral route 4 times per day 30 min before meals and at bedtime
Gastrointestinal food allergy
- 200 mg (2 ampules) and squeeze contents into a glass of water and stir by oral route 4 times per day 30 min before meals and at bedtime
Inflammatory bowel disease
- 200 mg (2 ampules) and squeeze contents into a glass of water and stir by oral route 4 times per day 30 min before meals and at bedtime
Maintenance therapy for asthma
- Inhale 2 milliliters (20 mg) by nebulization route 4 times per day
- Inhale 2 milliliters (20 mg) by nebulization route 3 times per day
- Inhale 2 milliliters (20 mg) by nebulization route 2 times per day
Systemic mastocytosis
- 200 mg (2 ampules) and squeeze contents into a glass of water and stir by oral route 4 times per day 30 min before meals and at bedtime
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Disease of liver
- Kidney disease with reduction in GFR
Severe
Moderate
- Severe hepatic disease
- Severe renal impairment
CROMOLYN SODIUM (CROMOLYN SODIUM)
- Maintenance therapy for asthma
- Systemic mastocytosis
- None
- Cough
- Diarrhea
- Dry throat
- Dysgeusia
- Headache disorder
- Nasal congestion
- Nausea
- Sore throat
- Xerostomia
More Frequent
Severe
Less Severe
- Pruritus of skin
- Skin rash
- Urticaria
- Eye tearing
- Hoarseness
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Allergic dermatitis
- Anaphylaxis
- Angioedema
- Arthralgias
- Arthritis
- Bronchospastic pulmonary disease
- Dizziness
- Dyspnea
- Dysuria
- Eosinophilic pneumonia
- Headache disorder
- Increased urinary frequency
- Laryngeal edema
- Muscle weakness
- Myalgias
- Pruritus of skin
- Severe headache disorder
- Skin rash
- Urticaria
Less Severe
- Abdominal pain with cramps
- Insomnia
- Irritability
- Myalgias
- Nausea
Contraindicated
None
Severe Precaution
Cromolyn sodium (Oral)
Weigh risk-benefit age < 2 yrs. Reserve for patient w/ severe disease.
- 1 Day – 2 Years
- Weigh risk-benefit age < 2 yrs. Reserve for patient w/ severe disease.
Management or Monitoring Precaution
Cromolyn (Inhalation, Nasal)
Safety and efficacy not established age < 2 years.
- 1 Day – 2 Years
- Safety and efficacy not established age < 2 years.
Cromolyn Sodium
- Severity Level:
B
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Cromolyn Sodium
Insufficient data available.
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Maintenance therapy for asthma | |
J45 | Asthma |
J45.2 | Mild intermittent asthma |
J45.20 | Mild intermittent asthma, uncomplicated |
J45.3 | Mild persistent asthma |
J45.30 | Mild persistent asthma, uncomplicated |
J45.4 | Moderate persistent asthma |
J45.40 | Moderate persistent asthma, uncomplicated |
J45.5 | Severe persistent asthma |
J45.50 | Severe persistent asthma, uncomplicated |
J45.9 | Other and unspecified asthma |
J45.90 | Unspecified asthma |
J45.909 | Unspecified asthma, uncomplicated |
Systemic mastocytosis | |
C96.21 | Aggressive systemic mastocytosis |
D47.02 | Systemic mastocytosis |
0-9 | A-Z |
---|---|
C96.21 | Aggressive systemic mastocytosis |
D47.02 | Systemic mastocytosis |
J45 | Asthma |
J45.2 | Mild intermittent asthma |
J45.20 | Mild intermittent asthma, uncomplicated |
J45.3 | Mild persistent asthma |
J45.30 | Mild persistent asthma, uncomplicated |
J45.4 | Moderate persistent asthma |
J45.40 | Moderate persistent asthma, uncomplicated |
J45.5 | Severe persistent asthma |
J45.50 | Severe persistent asthma, uncomplicated |
J45.9 | Other and unspecified asthma |
J45.90 | Unspecified asthma |
J45.909 | Unspecified asthma, uncomplicated |